Effector function of lymphokine-activated killer cells and cytotoxic T lymphocytes in ovarian epithelial carcinoma

This publication has 12 references indexed in Scilit:

• Phenotypic and functional characteristics of mononuclear cells in ovarian carcinoma tumors
  Gynecologic Oncology, 1989
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987
• Interleukin 2-activated human killer cells are derived from phenotypically heterogeneous precursors.
  The Journal of Immunology, 1986
• A New Approach to the Adoptive Immunotherapy of Cancer with Tumor-Infiltrating Lymphocytes
  Science, 1986
• Generation of lymphokine-activated killer (LAK) cells from tumor-infiltrating lymphocytes
  Cellular Immunology, 1986
• The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2
  Springer Seminars in Immunopathology, 1986
• Intraperitoneal immunotherapy of epithelial ovarian carcinoma with Corynebacterium parvum
  American Journal of Obstetrics and Gynecology, 1985
• Adoptive Immunotherapy of Established Pulmonary Metastases with LAK Cells and Recombinant Interleukin-2
  Science, 1984
• Mononuclear-cell infiltration in ovarian cancer. I. Inflammatory-cell infiltrates from tumour and ascites material
  British Journal of Cancer, 1982
• Chemoimmunotherapy for Advanced Ovarian Carcinoma With Adriamycin-Cyclophosphamide ± BCG: Early Report of a Southwest Oncology Group Study
  Published by Springer Nature ,1979